ArticleBlood advances2020

Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong.

Shing Fung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.